Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (GB:0IFR)
LSE:0IFR
EKSO BIONICS (0IFR) Share Price & Analysis
0 Followers
0IFR Stock Chart & Stats
Day’s Range$1.31 - $1.31
52-Week Range― - ―
Previous Close$1.2
Volume60.00
Average Volume (3M)N/A
Market Cap
$22.92M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Apr 29, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.25Price Target Upside606.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EKSO BIONICS News
PremiumPre-Earnings
Is EKSO a Buy, Before Earnings?
0IFR FAQ
What was EKSO BIONICS’s price range in the past 12 months?
Currently, no data Available
What is EKSO BIONICS’s market cap?
Currently, no data Available
When is EKSO BIONICS’s upcoming earnings report date?
EKSO BIONICS’s upcoming earnings report date is Apr 29, 2024 which is in 4 days.
How were EKSO BIONICS’s earnings last quarter?
EKSO BIONICS released its earnings results on Mar 04, 2024. The company reported -$0.22 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.11.
Is EKSO BIONICS overvalued?
According to Wall Street analysts EKSO BIONICS’s price is currently Undervalued.
Does EKSO BIONICS pay dividends?
EKSO BIONICS does not currently pay dividends.
What is EKSO BIONICS’s EPS estimate?
EKSO BIONICS’s EPS estimate is -$0.16.
How many shares outstanding does EKSO BIONICS have?
Currently, no data Available
What happened to EKSO BIONICS’s price movement after its last earnings report?
EKSO BIONICS reported an EPS of -$0.22 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went down -18.953%.
Which hedge fund is a major shareholder of EKSO BIONICS?
Currently, no hedge funds are holding shares in GB:0IFR
---
EKSO BIONICS Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.25 (606.11% Upside)
$9.25 (606.11% Upside)
Insider Transactions
Bought Shares
Worth $15.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.89%
12-Months-Change
Fundamentals
Return on Equity
-79.89%
Trailing 12-Months
Asset Growth
-29.30%
Trailing 12-Months
Company Description
EKSO BIONICS
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
---
0IFR Earnings Call
Q4 2024
0:00 / 0:00
---
0IFR Stock 12 Months Forecast
Average Price Target
$9.25
▲(606.11% Upside)
Technical Analysis
Smith & Nephew Snats
―
Rhythm Pharmaceuticals
―
Senseonics Holdings
―
Medtronic
―
EKSO BIONICS
―
Best Analysts Covering 0IFR
1 Year
1 Year Success Rate
1/11 ratings generated profit
1 Year Average Return
-32.11%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -32.11% per trade.
---